Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Adenosine receptors: therapeutic aspects for inflammatory and immune diseases Hasko G; Linden J; Cronstein B; Pacher PNat Rev Drug Discov 2008[Sep]; 7 (9): 759-70Adenosine is a key endogenous molecule that regulates tissue function by activating four G-protein-coupled adenosine receptors: A1, A2A, A2B and A3. Cells of the immune system express these receptors and are responsive to the modulatory effects of adenosine in an inflammatory environment. Animal models of asthma, ischaemia, arthritis, sepsis, inflammatory bowel disease and wound healing have helped to elucidate the regulatory roles of the various adenosine receptors in dictating the development and progression of disease. This recent heightened awareness of the role of adenosine in the control of immune and inflammatory systems has generated excitement regarding the potential use of adenosine-receptor-based therapies in the treatment of infection, autoimmunity, ischaemia and degenerative diseases.|Animals[MESH]|Autoimmune Diseases/*drug therapy/physiopathology[MESH]|Clinical Trials as Topic[MESH]|Disease Models, Animal[MESH]|Disease Progression[MESH]|Humans[MESH]|Inflammation/*drug therapy/physiopathology[MESH]|Ischemia/drug therapy/physiopathology[MESH]|Receptors, Purinergic P1/*drug effects/immunology/metabolism[MESH]|Signal Transduction[MESH] |